about
Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus.Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) PatientHypovitaminosis D and nocturnal hypertension in obese children: an interesting link.Newborn with rhizomelia and difficulty breathing.Food triggers and inherited metabolic disorders: a challenge to the pediatrician.Bone marrow features in Pearson syndrome with neonatal onset: A case report and review of the literature.Images from 18F-DOPA Scan in Congenital Hyperinsulinism: Not Always a Clue for Diagnosis.High-protein goat's milk diet identified through newborn screening: clinical warning of a potentially dangerous dietetic practice.Lysinuric protein intolerance can be misdiagnosed as food protein-induced enterocolitis syndrome.Painless bilateral swelling of the face: think about cherubism.A neonate with abdominal distension and failure to thrive.Short stature and high serum transaminase levels: growth hormone deficiency in a child with Becker muscular dystrophy.Significant association among growing pains, vitamin D supplementation, and bone mineral status: results from a pilot cohort studyBone density in children treated with gonadotropin-releasing hormone analogs for central precocious puberty.Serum inhibin B levels before and after varicocelectomy in early adolescenceFamilial cleidocranial dysplasia misdiagnosed as rickets over three generationsGenotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?Formulation and Clinical Evaluation of Sodium Benzoate Oral Solution for the Treatment of Urea Cycle Disorders in Pediatric Patients45,X/46,X,i(Yp): Importance of Assessment and Support during Puberty and AdolescenceHypocalcemia following Neridronate Administration in Pediatric Patients with Osteogenesis Imperfecta: A Prospective Observational Study
P50
Q30819915-FCF6AA56-96CB-4B73-BB77-8B6AE89EF3CAQ41619201-4EC03B38-BC04-4158-85EA-D209A1CADE2FQ44677643-042A649A-A477-4511-9BAE-F65F1F77F925Q48033994-AC9929FE-2B14-49C9-8B0D-FCFACAFFA3EAQ48168769-ECCA1AEA-2836-45AE-9DA8-6C8D421C8A40Q48331821-B599E773-7A3A-46F0-83DE-F440C3794E36Q49834406-5E4CDB23-82D9-4A86-80DD-BBE93A665765Q50875652-723E168B-241A-468B-8EF2-5297EF2826DAQ50902667-D30F0992-0F92-4E36-AC50-BE6AE40AAE1CQ53394073-0C0F3942-8CE4-421D-BE3F-1623FE69FC24Q53736781-ABB040FB-E393-4646-8333-47F5180D29A6Q54483739-198BC1A4-6435-458E-B43F-A78D77738039Q59201704-7A62C925-E091-4479-AEBA-2CFFD73B480CQ64998532-42E678A5-2398-4921-81C5-A4DD15F7A28BQ84340755-CB7DDF44-CE79-47D7-840C-F55496888E3BQ85927869-A05A80AB-8369-44F7-956C-BEC0E4B675F0Q86068364-4B726837-17DB-4F3F-86F0-FA130B61DE25Q90173152-882473EF-3BA8-40AD-BD3C-C5283242B273Q91557381-4F9984A4-53AD-403B-A811-33A195FCB156Q93272113-DFCAA7A4-C354-4E4A-8C54-58E66649AE73
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Evelina Maines
@ast
Evelina Maines
@en
Evelina Maines
@es
Evelina Maines
@nl
Evelina Maines
@sl
type
label
Evelina Maines
@ast
Evelina Maines
@en
Evelina Maines
@es
Evelina Maines
@nl
Evelina Maines
@sl
prefLabel
Evelina Maines
@ast
Evelina Maines
@en
Evelina Maines
@es
Evelina Maines
@nl
Evelina Maines
@sl
P106
P1153
35753601500
P31
P496
0000-0002-0445-2974